Pulse Biosciences, Inc. also files under PLSE; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Teplitsky Liane Rae | Chief Operating Officer | Buy(P) | 1K | $49.95 | $50K |
| Aug 31, 2026 | Teplitsky Liane Rae | Chief Operating Officer | Buy(P) | 1K | $48.80 | $50K |
| Aug 28, 2026 | Teplitsky Liane Rae | Chief Operating Officer | Buy(P) | 1K | $48.35 | $50K |
| Aug 26, 2026 | Teplitsky Liane Rae | Chief Operating Officer | Buy(P) | 1K | $48.24 | $50K |
| Aug 8, 2026 | Teplitsky Liane Rae | Chief Operating Officer | Grant(A) | 700K | — | $0 |
| Aug 8, 2026 | Teplitsky Liane Rae | Chief Operating Officer | Grant(A) | 200K | — | $0 |
| Jun 11, 2026 | Sainz Maria | Director | Grant(A) | 4K | — | $0 |
| Jun 11, 2026 | van den Broek Richard | Director | Grant(A) | 8K | — | $0 |
| Jun 11, 2026 | Duggan Robert W | Director, 10% Owner | Grant(A) | 12K | — | $0 |
| Jun 11, 2026 | Zanganeh Mahkam | Director | Grant(A) | 30K | — | $0 |
| Jun 11, 2026 | van den Broek Richard | Director | Grant(A) | 30K | — | $0 |
| Jun 11, 2026 | Duggan Robert W | Director, 10% Owner | Grant(A) | 30K | — | $0 |
| Jun 11, 2026 | Zanganeh Mahkam | Director | Grant(A) | 15K | — | $0 |
| Jun 11, 2026 | Sainz Maria | Director | Grant(A) | 30K | — | $0 |
| Jun 11, 2026 | Soni Manmeet Singh | Director | Grant(A) | 30K | — | $0 |
| May 11, 2026 | Duggan Robert W | Director, 10% Owner | Buy(P) | 660K | $19.69 | $13.0M |
| May 11, 2026 | Laviolette Paul A | Chief Executive Officer, Director | Buy(P) | 15K | $19.69 | $295K |
| Mar 23, 2026 | Uecker Darrin | Chief Technology Officer, Director | Grant(A) | 100K | — | $0 |
| Feb 18, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 5K | — | $0 |
| Feb 18, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Sell(S) | 5K | $23.64 | $118K |
| Feb 18, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 5K | $1.53 | $8K |
| Feb 17, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | $1.53 | $31K |
| Feb 17, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Sell(S) | 20K | $23.63 | $473K |
| Feb 17, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | — | $0 |
| Feb 13, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | — | $0 |
| Feb 13, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Sell(S) | 20K | $23.53 | $471K |
| Feb 13, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | $1.53 | $31K |
| Feb 12, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Sell(S) | 20K | $23.37 | $467K |
| Feb 12, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | — | $0 |
| Feb 12, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | $1.53 | $31K |
| Feb 11, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Sell(S) | 20K | $25.20 | $504K |
| Feb 11, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | — | $0 |
| Feb 11, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | $1.53 | $31K |
| Feb 10, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | $1.53 | $31K |
| Feb 10, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Sell(S) | 20K | $23.52 | $470K |
| Feb 10, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | — | $0 |
| Feb 9, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Sell(S) | 20K | $21.45 | $429K |
| Feb 9, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | — | $0 |
| Feb 9, 2026 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | $1.53 | $31K |
| Feb 5, 2026 | Sainz Maria | Director | Grant(A) | 3K | — | $0 |
| Jan 8, 2026 | Sainz Maria | Director | Grant(A) | 50K | — | $0 |
| Oct 2, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 5K | — | $0 |
| Oct 2, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Sell(S) | 5K | $18.53 | $85K |
| Oct 2, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 5K | $1.53 | $7K |
| Sep 19, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 400 | — | $0 |
| Sep 19, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 400 | $1.53 | $612 |
| Sep 19, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Sell(S) | 400 | $18.48 | $7K |
| Sep 18, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | — | $0 |
| Sep 18, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Sell(S) | 20K | $18.49 | $370K |
| Sep 18, 2025 | Danahy Kevin Patrick | Chief Commercial Officer | Option exercise(M) | 20K | $1.53 | $31K |
| Sep 17, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 20K | — | $0 |
| Sep 17, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 100K | — | $0 |
| Sep 17, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 62K | — | $0 |
| Sep 17, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 100K | $4.00 | $400K |
| Sep 17, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 20K | $4.00 | $80K |
| Sep 17, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 62K | $4.00 | $246K |
| Sep 17, 2025 | Uecker Darrin | Chief Technology Officer, Director | Sell(S) | 20K | $16.21 | $324K |
| Sep 16, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 25K | — | $0 |
| Sep 16, 2025 | Uecker Darrin | Chief Technology Officer, Director | Sell(S) | 25K | $16.28 | $407K |
| Sep 16, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 25K | $4.00 | $100K |
| Sep 15, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 25K | — | $0 |
| Sep 15, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 25K | $4.00 | $100K |
| Sep 15, 2025 | Uecker Darrin | Chief Technology Officer, Director | Sell(S) | 25K | $15.77 | $394K |
| Sep 12, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 25K | — | $0 |
| Sep 12, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 25K | $4.00 | $100K |
| Sep 12, 2025 | Uecker Darrin | Chief Technology Officer, Director | Sell(S) | 25K | $14.32 | $358K |
| Sep 11, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 25K | — | $0 |
| Sep 11, 2025 | Uecker Darrin | Chief Technology Officer, Director | Sell(S) | 25K | $14.78 | $370K |
| Sep 11, 2025 | Uecker Darrin | Chief Technology Officer, Director | Option exercise(M) | 25K | $4.00 | $100K |
| Sep 10, 2025 | Duggan Robert W | Director, 10% Owner | Buy(P) | 35K | $14.66 | $508K |
| Aug 15, 2025 | Duggan Robert W | Director, 10% Owner | Grant(A) | 30K | — | $0 |
| Aug 15, 2025 | Zanganeh Mahkam | Director | Grant(A) | 30K | — | $0 |
| Aug 15, 2025 | Duggan Robert W | Director, 10% Owner | Grant(A) | 21K | — | $0 |
| Aug 15, 2025 | Soni Manmeet Singh | Director | Grant(A) | 30K | — | $0 |
| Aug 15, 2025 | van den Broek Richard | Director | Grant(A) | 30K | — | $0 |
| Aug 15, 2025 | Zanganeh Mahkam | Director | Grant(A) | 24K | — | $0 |
| Jul 14, 2025 | Weber Steven | Principal Accounting Officer | Grant(A) | 55K | — | $0 |
| Jun 13, 2025 | Uecker Darrin | Chief Technology Officer, Director | Sell(S) | 15K | $15.98 | $240K |
| Jun 12, 2025 | Uecker Darrin | Chief Technology Officer, Director | Sell(S) | 15K | $16.40 | $246K |
| Feb 3, 2025 | Skinner Jon | Chief Financial Officer | Grant(A) | 300K | — | $0 |
| Feb 3, 2025 | Zanganeh Mahkam | Director | Option exercise(X) | 30K | — | $0 |
| Feb 3, 2025 | Zanganeh Mahkam | Director | Option exercise(X) | 30K | $11.00 | $331K |
| Jan 24, 2025 | Zanganeh Mahkam | Director | Option exercise(X) | 30K | — | $0 |
| Jan 24, 2025 | Zanganeh Mahkam | Director | Option exercise(X) | 30K | $11.00 | $331K |
| Jan 9, 2025 | Laviolette Paul A | Chief Executive Officer, Director | Grant(A) | 1.1M | — | $0 |
| Jan 9, 2025 | Laviolette Paul A | Chief Executive Officer, Director | Grant(A) | 450K | — | $0 |
| Dec 18, 2024 | Duggan Robert W | Director, 10% Owner | Option exercise(X) | 2.6M | — | — |
| Dec 18, 2024 | Duggan Robert W | Director, 10% Owner | Option exercise(X) | 25K | — | — |
| Dec 18, 2024 | Duggan Robert W | Director, 10% Owner | Option exercise(X) | 25K | — | — |
| Dec 18, 2024 | Duggan Robert W | Director, 10% Owner | Option exercise(X) | 35K | — | — |
| Dec 18, 2024 | Duggan Robert W | Director, 10% Owner | Option exercise(X) | 35K | — | — |
| Dec 18, 2024 | Duggan Robert W | Director, 10% Owner | Option exercise(X) | 2.6M | — | — |
| Dec 18, 2024 | Duggan Robert W | Director, 10% Owner | Option exercise(X) | 49K | $11.00 | $542K |
| Dec 18, 2024 | Duggan Robert W | Director, 10% Owner | Option exercise(X) | 69K | $11.00 | $759K |
| Dec 18, 2024 | Duggan Robert W | Director, 10% Owner | Option exercise(X) | 5.2M | $11.00 | $57.1M |
| Dec 13, 2024 | Duggan Robert W | Director, 10% Owner | Buy(P) | 55K | $17.18 | $949K |
| Dec 12, 2024 | Duggan Robert W | Director, 10% Owner | Buy(P) | 45K | $17.13 | $778K |
| Dec 11, 2024 | Duggan Robert W | Director, 10% Owner | Buy(P) | 6K | $16.74 | $101K |
| Dec 11, 2024 | Barrett Burke Thomas | Insider | Sell(S) | 50K | $17.42 | $871K |
| Dec 11, 2024 | Duggan Robert W | Director, 10% Owner | Buy(P) | 50K | $17.42 | $871K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Pulse Biosciences, Inc., SEC CIK 0001625101. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under PLES and shows every filing by that issuer (also filed as PLSE).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-15. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for PLES